Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

FDA approves Teva’s monthly injection of olanzapine for schizophrenia

Oct 12, 2026, 10:48 AM

Read Full Article → FDA approves Teva’s monthly injection of olanzapine for schizophrenia

FDA approves Teva’s monthly injection of olanzapine for schizophrenia

Translate article text

Choose a language and wait for the translated text.

Teva said it is debuting the drug to overcome adherence issues with an oral counterpart and improve symptom outcomes.

FDA approves Teva’s monthly injection of olanzapine for schizophrenia | PharmaVoice